Clinical Trials Directory

Trials / Completed

CompletedNCT01521637

The Efficacy of Neuromuscular Electrical Stimulation to Attenuate Muscle Loss

The Efficacy of Neuromuscular Electrical Stimulation to Attenuate Skeletal Muscle Loss in ICU Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Hasselt University · Academic / Other
Sex
Male
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Subjects who are hospitalized in the ICU will be included after 24 hours of intubation during their ICU stay. Twice-daily Neuromuscular Electrical Stimulation (NMES) will be performed on one leg for 2x40 min per day to assess muscle fiber size. The investigators hypothesize an attenuated loss in muscle fiber size.

Conditions

Interventions

TypeNameDescription
PROCEDURENeuromuscular Electrical Stimulation of m. quadriceps femorisNeuromuscular Electrical Stimulation of m. quadriceps femoris by using a commercially available muscle stimulator
PROCEDURESham-treatment: no NMESSham comparator

Timeline

Start date
2012-01-01
Primary completion
2015-04-01
First posted
2012-01-31
Last updated
2015-08-19

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01521637. Inclusion in this directory is not an endorsement.